These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2242262)

  • 21. Pure-tone threshold estimation from extrapolated distortion product otoacoustic emission I/O-functions in normal and cochlear hearing loss ears.
    Boege P; Janssen T
    J Acoust Soc Am; 2002 Apr; 111(4):1810-8. PubMed ID: 12002865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Studies of the evaluation of cochlea function with distortion product otoacoustic emission].
    Kashiwamura M
    Hokkaido Igaku Zasshi; 1998 Nov; 73(6):641-62. PubMed ID: 10036620
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dependence of distortion-product otoacoustic emissions on primary levels in normal and impaired ears. II. Asymmetry in L1,L2 space.
    Whitehead ML; Stagner BB; McCoy MJ; Lonsbury-Martin BL; Martin GK
    J Acoust Soc Am; 1995 Apr; 97(4):2359-77. PubMed ID: 7714255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Evoked otoacoustic emissions in humans with normal hearing].
    Sliwińska-Kowalska M; Sułkowski WJ; Murowaniecki Z
    Otolaryngol Pol; 1995; 49(1):46-56. PubMed ID: 7644200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distortion-product and click-evoked otoacoustic emissions in healthy newborns.
    Lafreniere D; Jung MD; Smurzynski J; Leonard G; Kim DO; Sasek J
    Arch Otolaryngol Head Neck Surg; 1991 Dec; 117(12):1382-9. PubMed ID: 1845266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Spontaneous otoacoustic emissions and efferent control of cochlea].
    Xu J; Liu C; Guo L; Lian N; Liu B
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Dec; 36(6):436-40. PubMed ID: 12761959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical applications of evoked acoustic emissions: results in normally hearing and hearing-impaired subjects.
    Bonfils P; Uziel A
    Ann Otol Rhinol Laryngol; 1989 May; 98(5 Pt 1):326-31. PubMed ID: 2719448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of primary frequencies ratio on distortion product otoacoustic emissions amplitude. II. Interrelations between multicomponent DPOAEs, tone-burst-evoked OAEs, and spontaneous OAEs.
    Moulin A
    J Acoust Soc Am; 2000 Mar; 107(3):1471-86. PubMed ID: 10738802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for the distortion product frequency place as a source of distortion product otoacoustic emission (DPOAE) fine structure in humans. II. Fine structure for different shapes of cochlear hearing loss.
    Mauermann M; Uppenkamp S; van Hengel PW; Kollmeier B
    J Acoust Soc Am; 1999 Dec; 106(6):3484-91. PubMed ID: 10615688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distortion product otoacoustic emissions in the elderly.
    Karzon RK; Garcia P; Peterein JL; Gates GA
    Am J Otol; 1994 Sep; 15(5):596-605. PubMed ID: 8572058
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distortion-product otoacoustic emissions. Values for clinical use.
    Bonfils P; Avan P
    Arch Otolaryngol Head Neck Surg; 1992 Oct; 118(10):1069-76. PubMed ID: 1389058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distortion product otoacoustic emissions. The influence of the middle ear transmission.
    Osterhammel PA; Nielsen LH; Rasmussen AN
    Scand Audiol; 1993; 22(2):111-6. PubMed ID: 8321995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distortion product otoacoustic emissions for hearing threshold estimation and differentiation between middle-ear and cochlear disorders in neonates.
    Janssen T; Gehr DD; Klein A; Müller J
    J Acoust Soc Am; 2005 May; 117(5):2969-79. PubMed ID: 15957767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Auditory threshold evaluation by distortion-product oto-acoustic emissions using decision support system.
    Bonfils P; Avan P; Elbez M; Deys S; Erminy M; François M
    Acta Otolaryngol; 1994 Jul; 114(4):360-5. PubMed ID: 7976306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hearing threshold estimation using concurrent measurement of distortion product otoacoustic emissions and auditory steady-state responses.
    Rosner T; Kandzia F; Oswald JA; Janssen T
    J Acoust Soc Am; 2011 Feb; 129(2):840-51. PubMed ID: 21361442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distortion product otoacoustic emissions in hearing-impaired mutant mice.
    Horner KC; Lenoir M; Bock GR
    J Acoust Soc Am; 1985 Nov; 78(5):1603-11. PubMed ID: 4067076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The clinical use of oto-acoustic emissions of cochlear distortion products].
    Hauser R; Probst R; Harris FP
    Laryngorhinootologie; 1991 Mar; 70(3):123-31. PubMed ID: 2036146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD1 hearing-impaired mice. II. Group latencies and optimal f2/f1 ratios of distortion product otoacoustic emissions, and scanning electron microscopy.
    Le Calvez S; Guilhaume A; Romand R; Aran JM; Avan P
    Hear Res; 1998 Jun; 120(1-2):51-61. PubMed ID: 9667430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Objective low-frequency audiometry by distortion-product acoustic emissions.
    Bonfils P; Avan P; Londero A; Trotoux J; Narcy P
    Arch Otolaryngol Head Neck Surg; 1991 Oct; 117(10):1167-71. PubMed ID: 1910706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of inner ear hearing loss on delayed otoacoustic emissions (TEOAE) and distortion products (DPOAE)].
    Hoth S
    Laryngorhinootologie; 1996 Dec; 75(12):709-18. PubMed ID: 9081275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.